A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies
A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies
Recruiting · NCT06820268 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-09-25 | NCT06820268 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 24 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Hospital of Hebei University | Hebei | China | 2 |
| Beijing Cancer Hospital | Beijing | China | 85 |
| Sun Yat-sen University Cancer Center | Guangdong | China | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Hubei | China | 5 |